title: Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.
authors.affiliation: From Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (K.C.S.); and Division of Health Care Policy and Research, Department of Health Sciences Research (X.Y.) and Division of Cardiovascular Diseases (B.J.G., P.A.N.), Mayo Clinic, Rochester, MN.
authors.forename: Konstantinos C
authors.initials: KC
authors.lastname: Siontis
authors.affiliation: From Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (K.C.S.); and Division of Health Care Policy and Research, Department of Health Sciences Research (X.Y.) and Division of Cardiovascular Diseases (B.J.G., P.A.N.), Mayo Clinic, Rochester, MN.
authors.forename: Xiaoxi
authors.initials: X
authors.lastname: Yao
authors.affiliation: From Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (K.C.S.); and Division of Health Care Policy and Research, Department of Health Sciences Research (X.Y.) and Division of Cardiovascular Diseases (B.J.G., P.A.N.), Mayo Clinic, Rochester, MN.
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Gersh
authors.affiliation: From Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (K.C.S.); and Division of Health Care Policy and Research, Department of Health Sciences Research (X.Y.) and Division of Cardiovascular Diseases (B.J.G., P.A.N.), Mayo Clinic, Rochester, MN. Noseworthy.Peter@mayo.edu.
authors.forename: Peter A
authors.initials: PA
authors.lastname: Noseworthy
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006349:Heart Valve Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male
chemical_list: D000925:Anticoagulants
keywords: anticoagulant; atrial fibrillation; meta-analysis; valve